Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20132908Phase 2Active
A Phase 2 trial of antiviral lozenge in neurodermatitis, atopic dermatitis (AD), sponsored by Beijing Incuris Biological Products Research Institute. Started Jul 2014; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20132908.